Increase genomic surveillance to monitor and respond to new COVID-19 variants with immune escape potential.
Pandemics
Pandemics Risk
Assessment for this date
The current pandemic risk is high due to the emergence of a new COVID variant with immune escape potential, ongoing avian flu outbreaks, and significant pediatric flu mortality.
March 31, 2026
Trend
Viewing the record for March 31, 2026 within the full trend.
Risk Drivers
What is pushing the current reading.
The emergence of a new COVID-19 variant with immune escape potential across multiple countries, including the US, raises concerns about potential increases in transmission and vaccine efficacy challenges. Concurrently, avian flu outbreaks are affecting poultry and wildlife across several regions, posing risks of zoonotic transmission and economic impacts. Additionally, the high number of pediatric flu deaths indicates a severe flu season, further straining healthcare systems. These factors, combined with low antiviral use among high-risk populations and potential underreporting of COVID-19 deaths, underscore the need for heightened vigilance and response efforts.
Risk Reduction Actions
Priority actions generated from the current analysis.
Enhance vaccination campaigns and ensure high-risk populations have access to antiviral treatments.
Strengthen communication strategies to combat misinformation and improve public trust in vaccines.
Support international efforts to control avian flu outbreaks and prevent zoonotic transmission.
Accelerate development and deployment of next-generation vaccines targeting emerging pathogens.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- New COVID variant with immune escape potential confirmed in US, 22 other countries
- CDC reports 14 more pediatric flu deaths, 115 total
- Up to 60% of health care workers may have long COVID 4 years after infection
- Avian flu hits farms in Pennsylvania, Maryland, Michigan, Indiana
- Cambodia confirms its first human case of H5N1 avian flu this year